PMC:7275193 / 9920-10501 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T150","span":{"begin":60,"end":72},"obj":"GO:0030097"},{"id":"T151","span":{"begin":302,"end":316},"obj":"GO:0030097"},{"id":"T152","span":{"begin":516,"end":533},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T153","span":{"begin":534,"end":545},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T69516","span":{"begin":60,"end":72},"obj":"GO:0030097"},{"id":"T80139","span":{"begin":302,"end":316},"obj":"GO:0030097"},{"id":"T58266","span":{"begin":516,"end":533},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T70796","span":{"begin":534,"end":545},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T42","span":{"begin":274,"end":282},"obj":"Body_part"}],"attributes":[{"id":"A42","pred":"fma_id","subj":"T42","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T55","span":{"begin":0,"end":11},"obj":"Phenotype"},{"id":"T56","span":{"begin":60,"end":72},"obj":"Phenotype"},{"id":"T57","span":{"begin":77,"end":87},"obj":"Phenotype"},{"id":"T58","span":{"begin":117,"end":133},"obj":"Phenotype"},{"id":"T59","span":{"begin":274,"end":288},"obj":"Phenotype"},{"id":"T60","span":{"begin":386,"end":403},"obj":"Phenotype"}],"attributes":[{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A56","pred":"hp_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/HP_0001974"},{"id":"A57","pred":"hp_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/HP_0001882"},{"id":"A58","pred":"hp_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/HP_0001873"},{"id":"A59","pred":"hp_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A60","pred":"hp_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/HP_0003281"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T111","span":{"begin":0,"end":11},"obj":"Disease"},{"id":"T112","span":{"begin":77,"end":87},"obj":"Disease"},{"id":"T113","span":{"begin":117,"end":133},"obj":"Disease"},{"id":"T114","span":{"begin":292,"end":336},"obj":"Disease"},{"id":"T115","span":{"begin":302,"end":336},"obj":"Disease"}],"attributes":[{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0003785"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0002049"},{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0015542"},{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0015540"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T126","span":{"begin":429,"end":431},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T127","span":{"begin":475,"end":476},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T128","span":{"begin":557,"end":558},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T84","span":{"begin":0,"end":50},"obj":"Sentence"},{"id":"T85","span":{"begin":51,"end":116},"obj":"Sentence"},{"id":"T86","span":{"begin":117,"end":245},"obj":"Sentence"},{"id":"T87","span":{"begin":246,"end":433},"obj":"Sentence"},{"id":"T88","span":{"begin":434,"end":581},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"TEST0","denotations":[{"id":"32547383-57-63-2084735","span":{"begin":108,"end":110},"obj":"[\"32007143\"]"},{"id":"32547383-124-130-2084736","span":{"begin":241,"end":243},"obj":"[\"32178975\"]"},{"id":"32547383-183-189-2084737","span":{"begin":429,"end":431},"obj":"[\"32192578\"]"},{"id":"32547383-143-149-2084738","span":{"begin":577,"end":579},"obj":"[\"32171076\"]"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"2_test","denotations":[{"id":"32547383-32007143-18888167","span":{"begin":108,"end":110},"obj":"32007143"},{"id":"32547383-32178975-18888168","span":{"begin":241,"end":243},"obj":"32178975"},{"id":"32547383-32192578-18888169","span":{"begin":429,"end":431},"obj":"32192578"},{"id":"32547383-32171076-18888170","span":{"begin":577,"end":579},"obj":"32171076"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"304","span":{"begin":152,"end":160},"obj":"Species"},{"id":"305","span":{"begin":251,"end":259},"obj":"Species"},{"id":"306","span":{"begin":0,"end":11},"obj":"Disease"},{"id":"307","span":{"begin":60,"end":72},"obj":"Disease"},{"id":"308","span":{"begin":77,"end":87},"obj":"Disease"},{"id":"309","span":{"begin":117,"end":133},"obj":"Disease"},{"id":"310","span":{"begin":302,"end":336},"obj":"Disease"},{"id":"311","span":{"begin":371,"end":408},"obj":"Disease"}],"attributes":[{"id":"A304","pred":"tao:has_database_id","subj":"304","obj":"Tax:9606"},{"id":"A305","pred":"tao:has_database_id","subj":"305","obj":"Tax:9606"},{"id":"A306","pred":"tao:has_database_id","subj":"306","obj":"MESH:D008231"},{"id":"A307","pred":"tao:has_database_id","subj":"307","obj":"MESH:D007964"},{"id":"A308","pred":"tao:has_database_id","subj":"308","obj":"MESH:D007970"},{"id":"A309","pred":"tao:has_database_id","subj":"309","obj":"MESH:D013921"},{"id":"A310","pred":"tao:has_database_id","subj":"310","obj":"MESH:D051359"},{"id":"A311","pred":"tao:has_database_id","subj":"311","obj":"MESH:C538137"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Lymphopenia is the most common laboratory finding. However, leukocytosis and leukopenia have been reported [19, 20]. Thrombocytopenia is more common in patients with critical diseases, and it could distinguish between mild and severe cases [21]. Some patients might develop cytokine storm or secondary hemophagocytic lymphohistiocytosis, which is characterized mainly by cytopenias and hyperferritinemia plus the other features [22]. Usually, these complications occur after a few days of disease onset and being on immunosuppressive medications could have a protective value [23]."}